MedTrace Logo

Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy

NCT00373035 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-01-19

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of blood and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at biomarkers in patients undergoing transrectal ultrasound prostate biopsy.

Conditions

Interventions

GENETIC

proteomic profiling

OTHER

immunological diagnostic method

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

PROCEDURE

biopsy

PROCEDURE

ultrasound imaging

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Frank M. Torti, MD, MPH · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2006-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00373035 on ClinicalTrials.gov